Shant Manoushagian, MD
Cardiovascular Disease · Fort Myers, FLNPI 1205191699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Abbott at 29.4% of the total.
Across 84 payments — averaging $85.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Heartflow, Inc.$2K
- Siemens Medical Solutions USA, Inc.$997
- Cvrx, Inc.$574
- Boehringer Ingelheim$468
- AstraZeneca$464
- plus $884 from 8 others
Across 7 payments — averaging $1542.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sarepta Therapeutics, Inc.$11K
What the payments were for
- Food & beverage$7,198100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $2,119 |
| Heartflow, Inc. | 19 | $1,692 |
| Siemens Medical Solutions USA, Inc. | 10 | $997 |
| Cvrx, Inc. | 4 | $574 |
| Boehringer Ingelheim | 4 | $468 |
| AstraZeneca | 4 | $464 |
| Novartis | 3 | $247 |
| Biotronik Inc. | 2 | $192 |
| Arineta, Inc | 1 | $162 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Pfizer | 3 | $63 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $44 |
| Amgen | 2 | $35 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$1,380
- CARDIOMEMS$680
- Barostim Neo System$574
- FARXIGA$376
- JARDIANCE$369
- CardioMEMS HF System$310
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$287
- ACUSON SC2000 Diagnostic Ultrasound System$286
- Mitra Clip system$242
- SOMATOM Pro.Pulse$241
- ENTRESTO$228
- CardioGraphe$162
- HeartMate 3 Left Ventricular Dev$129
- ONPATTRO$125
- MitraClip$104
How this compares
$7,198 in reported general payments places this provider in the 70th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 38 | $639 |
| Metoprolol Succinate | 35 | $593 |
| Losartan Potassium | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Fort Myers
- Malissa WoodFort Myers$250K
- Michael LipinskiFort Myers$247K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.